Press release
The Ineffective Esophageal Motility Treatment Market to Adopt Digitization
Ineffective esophageal motility treatment leads to a reduction in muscle damage and improved outcomes, improving quality of life and resulting in long-term benefits. Device-based treatment and IEMT drugs have already had a substantial impact on how symptoms of GERD and achalasia are treated. The first and the most important factor driving the growth of the ineffective esophageal motility treatment market is the increasing prevalence of gastroesophageal reflux disease. Other factors, such as intake of asthma medications and increasing geriatric population, are also responsible for driving the ineffective esophageal motility treatment market.
To remain ‘ahead’ of your competitors, request for a sample @ https://www.persistencemarketresearch.com/samples/31550
According to the latest report published by PMR, the global ineffective esophageal motility treatment market is projected to expand at a decent CAGR of around 6% during the forecast period (2020–2030).
Get a Customized Scope to Match Your Need Ask an Expert- sales@persistencemarketresearch.com
Key Takeaways from Ineffective Esophageal Motility Treatment Market Study
Significant advantages of ineffective esophageal motility treatment; improving reimbursement scenario for surgical treatment devices; increasing awareness regarding gastric reflux disease; and large patient pool for GERD, dysphagia, achalasia, and burning chest pain are key factors propelling the growth of ineffective esophageal motility treatment market in developing regions.
North America is a prominent region the global ineffective esophageal motility treatment market, while East Asia is expected to offer lucrative growth opportunities, owing to the large population base and higher incidence of GERD and dysphagia.
Higher OTC antacid consumption is poised to drive the growth of the market.
Radiofrequency ablation systems with high level precision and procedural advantages over myotomy are expected to generate significant revenue in the long term.
Increasing adoption of ineffective esophageal motility treatment drugs for quick recovery as compared to device-based treatment marks higher revenue potential.
Raw material procurement issues, drug shortages, and reduced patient visits amidst the COVID-19 pandemic will adversely affect the growth of the ineffective esophageal motility treatment market in the near term.
“Procedural accuracy achieved by treatment devices and affordability of drug-based treatment are anticipated to drive the ineffective esophageal motility treatment market. Additionally, the large patient pool will bring in steady revenue opportunities,” says a PMR analyst.
For critical insights, request for methodology @ https://www.persistencemarketresearch.com/methodology/31550
Company Profiles:
Johnson & Johnson
Mylan Pharmaceutical
MediGus Ltd.
Torax Medical
Medtronic plc.
AstraZeneca plc.
Teva Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
GlaxoSmithKline plc.
Bayer AG
Pfizer Inc.
Bausch Health Companies Inc.
LABORIE
Mederi Therapeutics, Inc.
Becton, Dickinson and Company (C. R. Bard, Inc.)
EndoGastric Solutions, Inc
Olympus
Pentax
New Product Launches by Key Players to Strengthen Market Presence
Key manufacturers in the ineffective esophageal motility treatment market are mainly focusing on research & development and introduction new & advanced treatment products. For example, LINX is the new and advanced version of the LINX reflux management device that is used for the transoral incision-less fundoplication process, which is one of the important procedures for the treatment of gastroesophageal reflux disease. The innovation of new & advanced products is a factor boosting the ineffective esophageal motility treatment market. In addition, Olympus Corporation has launched advanced versions of esophagoscopes, which have improved the treatment curve of gastroesophageal reflux disease. Manufacturers are focusing on extended indication list and higher reimbursement to draw demand and increase profitability. Alternatively, a key factor affecting the ineffective esophageal motility treatment market is the entry of generic drug manufacturers. Market leaders are constantly working on strengthening their strategies to gain market share.
For in-depth competitive analysis, buy now @ https://www.persistencemarketresearch.com/checkout/31550
What else is in the report?
Persistence Market Research offers a unique perspective and actionable insights on the ineffective esophageal motility treatment market in its latest study, presenting historical demand assessment of 2015–2019 and projections for 2020–2030, on the basis of product (drugs and devices), indication (GERD, dysphagia, achalasia, and burning chest pain), and end user (institutional sales and retail sales), across seven key regions.
Complete Report Details@ https://www.persistencemarketresearch.com/market-research/ineffective-esophageal-motility-treatment-market.asp
Read More Trending "PMR Exclusive Article"-
Sterile Injectable Drugs Market@ https://www.persistencemarketresearch.com/market-research/sterile-injectable-drugs-market.asp
Intravitreal Ivt Injectable Market@ https://www.persistencemarketresearch.com/market-research/intravitreal-ivt-injectable-market.asp
Contact us:
305 Broadway, 7th Floor
New York City, NY 10007 United States
Ph.no. +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com
About us-
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on “micros” by Persistence Market Research helps companies overcome their “macro” business challenges
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Ineffective Esophageal Motility Treatment Market to Adopt Digitization here
News-ID: 2500214 • Views: …
More Releases from Persistence Market Research
Socks Market to Reach US$89.9 Billion by 2032 on Rising Fashion and Performance …
Introduction
The global socks market has emerged as a dynamic and fast-evolving segment within the broader apparel and textile industry, driven by changing consumer lifestyles, rising fashion consciousness, and increasing demand for comfort-focused clothing essentials. Socks, once viewed purely as a functional necessity, have now evolved into a key fashion accessory and performance wear component across casual, formal, athletic, and medical applications.
➤ Download Your Free Sample & Explore Key Insights: https://www.persistencemarketresearch.com/samples/13948
With…
Energy Drink Mix Powder Market Value to Reach US$3.9 Bn by 2032 Driven by Fitnes …
The global energy drink mix powder market is poised for sustained expansion over the coming years, driven by shifting consumer lifestyles, growing health awareness, and the increasing demand for convenient functional beverages. In 2025, the market size is likely to be valued at approximately US$2.4 billion, reflecting steady adoption across both developed and emerging economies. Over the forecast period from 2025 to 2032, the market is projected to reach US$3.9…
Sacha Inchi Market Value to Reach US$390.1 Mn by 2032 Driven by Rising Demand fo …
The global sacha inchi market is gaining significant traction as consumer preferences continue to shift toward plant-based, nutrient-dense, and sustainably sourced ingredients. Sacha inchi, also known as the Inca peanut, is increasingly recognized for its high omega-3 fatty acid content, complete protein profile, and antioxidant properties, positioning it as a premium ingredient across food, nutraceutical, cosmetic, and pharmaceutical applications. In 2025, the global sacha inchi market size is likely to…
Next-Gen Connectivity: Wireless Chipsets Market Trends and Forecast
Overview of the Wireless Chipsets Market
The global wireless chipsets market has witnessed significant growth over the past decade, driven by increasing demand for seamless connectivity and smart, IoT-enabled devices. In 2025, the market is projected to be valued at US$ 22.5 billion and is expected to reach US$ 35.3 billion by 2032, reflecting a CAGR of 6.6% during the forecast period 2025-2032. The growth is fueled by the expansion of…
More Releases for Ineffective
Ineffective Esophageal Motility Treatment Market Poised for Expansion, Notes Per …
The global Ineffective Esophageal Motility (IEM) Treatment Market has entered a period of sustained growth, propelled by rising gastrointestinal disorders and increasing awareness of esophageal motility diseases. Valued at US$ 4.21 billion in 2023, the market is projected to nearly double and reach US$ 7.47 billion by 2033, expanding at a steady 5.9% CAGR. IEM, often associated with conditions such as gastroesophageal reflux disease (GERD), dysphagia, and hiatal hernia, is…
Terischwartz Associates Exposes the True Cost of Ineffective Meetings in Today's …
Image: https://www.abnewswire.com/upload/2025/07/3cd3e20ec6c36670720e5834999ed2ab.jpg
Executives across the country sit in boardrooms and virtual rooms alike, facing a steady stream of meetings that move agendas sideways, not forward. At the center of this epidemic lies a rarely acknowledged truth: most meetings lack a clear purpose, structure, or outcome. Despite their ubiquity, they remain one of the greatest hidden inefficiencies in modern business.
Evan Unger [https://www.terischwartzassociates.com/our-team/evan-unger/], managing partner at a national leadership consulting firm, studies this…
Steep learning curve and ineffective customer support keep AccountEdge second to …
Brandon, MB--May 25, 2023: AccountEdge helps small businesses establish inventory, billing, managing contacts, creating and tracking sales and purchases. It's compatible with both Mac and Windows operating systems. An on-premise and accounting management solution, it gives users the freedom to create an eCommerce platform where they can sell items online using Shopify, download orders directly to the account and synchronize the inventory items for selling. The banking tool gives…
Ineffective Esophageal Motility Treatment Market 2022 Global Market Analysis and …
Ineffective esophageal motility treatment leads to a reduction in muscle damage and improved outcomes, improving quality of life and resulting in long-term benefits. Device-based treatment and IEMT drugs have already had a substantial impact on how symptoms of GERD and achalasia are treated.
The first and the most important factor driving the growth of the ineffective esophageal motility treatment market is the increasing prevalence of gastroesophageal reflux disease. Other factors, such…
The Ineffective Esophageal Motility Treatment Market to keep pace with the lates …
The Ineffective Esophageal Motility Treatment Market is expected to witness a staggering CAGR going forward. The gamut of care is being driven by the usage of sensors, digital technologies, and wearables, thereby allowing the healthcare personnel to delve deep into the patients’ live – be it pre-operative, post-operative, or the period in between. Consumer tech companies are into making caregivers visible outside of the clinical environment a reality.
Ineffective esophageal…
IAS Questions MoH Push for Ineffective Vaccine
The Immunisation Awareness Society is raising concern about the inadequate level of information provided to the public regarding the whooping cough vaccine.
Auckland, New Zealand, April 11, 2012 -- GIVEN the current push by the Ministry of Health (MoH) for people to get their whooping cough (pertussis) vaccinations, the Immunisation Awareness Society (IAS) is raising concerns about the inadequate level of information provided around vaccination in New Zealand.
The latest figures from…
